Investing.com– Morgan Stanley (NYSE:MS) decreased its value goal for Foot Locker Inc (NYSE:FL), citing continued considerations over the retailer’s means to execute a turnaround, after its disappointing third-quarter earnings and a downgrade to full-year steerage.
Foot Locker’s third-quarter outcomes missed expectations, with earnings per share falling brief as a consequence of weak comparable gross sales and gross margin efficiency. Whereas some classes, equivalent to youngsters’s footwear, confirmed modest positive factors, Morgan Stanley characterised these enhancements as primarily promotion-driven.
Morgan Stanley lowered its value goal to $16 from $17, maintains “Underweight” ranking on Foot Locker.
Administration lowered its full-year earnings steerage to a variety of $1.20 to $1.30 per share, down from earlier forecasts, a revision Morgan Stanley described as extra extreme than the third-quarter earnings shortfall alone.
The brokerage additionally lowered Foot Locker’s earnings steerage to $1.20 per share, under its earlier expectation of $1.36 apiece.
Morgan Stanley analysts mentioned they have been skeptic about Foot Locker’s optimistic projections for the fourth quarter, particularly in gentle of ongoing promotional pressures and a difficult vacation retail atmosphere.
The funding financial institution additionally flagged structural points that would weigh on firm’s long-term progress. These embrace the shift towards direct-to-consumer methods by main manufacturers like Nike (NYSE:NKE), restricted e-commerce penetration, and the challenges of managing a big retailer footprint in a declining mall-based retail atmosphere.
The agency stays “Underweight” on Foot Locker, citing dangers to earnings for each the close to and medium time period.
Foot Locker is scheduled to report fourth-quarter earnings in early 2025, with analysts watching carefully for indicators of stabilization or additional headwinds.
Prudential Monetary Inc. (NYSE:PRU), a world chief within the insurance coverage and monetary providers sector…
(This Jan. 15 story has been refiled with an amended remark from the WEF Managing…
(Reuters) - The U.S. authorities on Friday introduced a listing of 15 prescription medicines focused…
BEIJING (Reuters) -China's economic system ended 2024 on higher footing than anticipated helped by a…
Investing.com -- U.S. President-elect Donald Trump introduced the launch of his meme coin, $TRUMP, in a…
Elizabeth L. Hougen, Government Vice President, Finance & CFO of Ionis Prescription drugs Inc. (NASDAQ:IONS),…